P

Active Director Director DIN 03262483
DIN 03262483 First appointment Jan 2012 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2012
Shareholding value •••• Premium profile

About Poonam

Data last updated:

Poonam is a Director at Sarvlife Pharmaceuticals Private Limited (since 2012). The company operates in Trading. Sarvlife Pharmaceuticals Private Limited reported revenue of ₹10.1 Lakh (FY 2020).

DIN 03262483
Primary Designation Director
Industry Trading
First Appointment 15 Jan 2012
Oldest Company Age 33 yrs
Largest company Sarvlife Pharmaceuticals Private Limited · ₹10.1 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Jan 20121993₹10.1 Lakh (FY 2020)Active

Board colleagues of Poonam

NameDINCompanyDesignation
Sanjeev Goyal03205755Sarvlife Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sarvlife Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Poonam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Poonam

Poonam currently holds 1 directorship: Sarvlife Pharmaceuticals Private Limited (Director, since 15 Jan 2012, revenue ₹10.1 Lakh (FY 2020)).

Poonam was first appointed on 15 Jan 2012 as Director at Sarvlife Pharmaceuticals Private Limited.

The current boards of Poonam's companies include Sanjeev Goyal (Sarvlife Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available